Trial intelligence / Profile preview

DermaPro (diperoxochloric acid) vs saline in venous leg ulcers

2014-001001-40Phase 2Terminated

Sponsor
DermaTools Biotech
Start
Apr 2014
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of DermaPro in stasis ulcer (2 arms), sponsored by DermaTools Biotech. Primary endpoint: Complete wound closure. Started Apr 2014; status: terminated.

02

Drugs

DermaPro
03

Conditions

stasis ulcer

Beyond the preview

Go deeper on 2014-001001-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-001001-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call